Teva Pharmeceutical Industries said Sunday it expects to close its acquisition of Ivax Corporation by January 12.
Teva agreed to buy Ivax in July for $7.4 billion, the largest ever acquisition by an Israeli company.
The companies said they have signed a consent order for submission to the US Federal Trade Commision (FTC) which is "the last remaining regulatory condition to the consummation of the transaction."
cnxps.cmd.push(function () { cnxps({ playerId: '36af7c51-0caf-4741-9824-2c941fc6c17b' }).render('4c4d856e0e6f4e3d808bbc1715e132f6'); });
if(window.location.pathname.indexOf("656089") != -1){console.log("hedva connatix");document.getElementsByClassName("divConnatix")[0].style.display ="none";}
